Gene · 6258
Papers895
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 895
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In Silico Multitarget Profiling of Betulinic Acid: ADME/Protox-II Toxicity, Network Pharmacology, and Molecular Docking for Diabetic Osteoporosis. | Curr Drug Discov Technol | 2026 | 42634321 | PubTator, text mining | PubMed |
| Integrative single-nucleus transcriptomic analysis identifies UBE2C+ proliferative tumor cells and immune-stromal regulatory crosstalk in small cell lung cancer. | Front Immunol | 2026 | 42614523 | PubTator, text mining | PubMed |
| Psoralen enhances direct cardiac reprogramming via activating PPARα and driving mitochondrial fission and improves cardiac function after myocardial infarction. | Stem Cell Res Ther | 2026 | 42421106 | PubTator, text mining | PubMed |
| Liver endothelial zonation orchestrates hepatic steatosis onset through retinoic acid-regulated FGF1. | Sci Adv | 2026 | 42319926 | PubTator, text mining | PubMed |
| Quadruple immunotherapy with allogeneic natural killer cell infusion for recurrent neuroblastoma. | Cytotherapy | 2026 | 42202757 | PubTator, text mining | PubMed |
| Towards a unified molecular mechanism for ligand-dependent activation of NR4A-RXR heterodimers. | Elife | 2026 | 42059885 | PubTator, text mining | PubMed |
| Epigenetic dichotomy in florid vs. gliotic proliferative diabetic retinopathy: hypomethylation of EGLN1 and MMP9 drives divergent pathogenic pathways in angiogenesis and fibrosis. | Front Endocrinol (Lausanne) | 2026 | 41958874 | PubTator, text mining | PubMed |
| RXR Gamma Enables Oligodendrocyte Differentiation by Suppressing Sonic Hedgehog Signaling. | Glia | 2026 | 41934103 | PubTator, text mining | PubMed |
| Copper deficiency impairs oligodendrocyte maturation and social behavior via mitophagy and mTOR suppression in ASD. | Sci Adv | 2026 | 41920999 | PubTator, text mining | PubMed |
| Deciphering the cardiac neuron landscape in heart failure patients. | PLoS Comput Biol | 2026 | 41860822 | PubTator, text mining | PubMed |
| Retinal organoid screening reveals ABT-737 and luminespib as potential agents against a cone- precursor-derived subtype of retinoblastoma. | Mol Ther Oncol | 2026 | 41809370 | PubTator, text mining | PubMed |
| From Gas Chromatography-Mass Spectrometry (GC-MS) to Network Pharmacology: System-Level Insights into the Multi-Target Biological Potential of Flaveria trinervia (Spreng.) C. Mohr. | Curr Issues Mol Biol | 2026 | 41751423 | PubTator, text mining | PubMed |
| Gene regulatory network transitions reveal the central transcription factors in lung adenocarcinoma progression. | NPJ Syst Biol Appl | 2026 | 41559111 | PubTator, text mining | PubMed |
| Transcriptome Sequencing Identifies PCK1 and IRS4 as Key Regulators of Gestational Diabetes Mellitus in Placenta: A Pilot Study. | Diabetes Metab Syndr Obes | 2025 | 41179578 | PubTator, text mining | PubMed |
| Genetic and serum biomarkers of NSAID hypersensitivity reactions. | Front Pharmacol | 2025 | 41111521 | PubTator, text mining | PubMed |
| Retinoid X receptor γ interacts with peroxisome proliferator-activated receptor-γ to promote browning during adipose tissue differentiation. | Adipocyte | 2025 | 40855678 | PubTator, text mining | PubMed |
| Modeling combinatorial regulation from single-cell multi-omics provides regulatory units underpinning cell type landscape using cRegulon. | Genome Biol | 2025 | 40707940 | PubTator, text mining | PubMed |
| PS77: a novel peptide with α-helical structure for targeted anti-inflammatory therapy in biomaterials design. | Immunol Res | 2025 | 40705171 | PubTator, text mining | PubMed |
| RXRG as a Novel Biomarker and its Correlation With Immune Infiltration in Thyroid Carcinoma. | In Vivo | 2025 | 40578996 | PubTator, text mining | PubMed |
| Retinoid X receptor γ regulates epithelial-mesenchymal transition and tumor immune infiltration in papillary thyroid cancer tumorigenesis: an experimental and in silico study. | Endocr Connect | 2025 | 40465540 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6258/papers